Document:

Employment Agreement

 Exhibit 10.1 
  
 August 11, 2005 
  
 Mr. Edmund A. Stanczak, Jr. 
  
 1397 Coles Avenue 
 Mountainside, New Jersey 07092 
  
 Dear
Mr. Stanczak: 
  
 Propex Fabrics Inc. (“Propex”) is pleased to offer
(the “Offer”) you employment as President and CEO of Propex Fabrics Inc., effective August 16, 2005. It is anticipated that you will also serve as a Director of Propex during your employment, if you are properly appointed or elected as
legally required. 
  
 The following are the components of the Offer: 

 

	 	1.	Compensation. You will receive an annual salary of $345,000 (“Annual Salary”) subject to statutory withholdings and deductions. Your Annual Salary will be pro-rated
for 2005. 

  

	 	2.	Vacation: You will be granted 160 hours of vacation annually during the term of your employment beginning January 1, 2006. For 2005, you will be eligible to use half of this
benefit after completing four months of credited service (80 hours for the remainder of 2005). 

  

	 	3.	Relocation: You will be reimbursed for your reasonable relocation expenses incurred within a period of one year from your first day at work. 

  

	 	4.	Confidentiality Agreement; Compliance with Policies. As a condition of your employment, you will be required to execute the attached Information and Invention Agreement
(“Confidentiality Agreement”) and comply with all company policies of Propex and its affiliated companies. 

  

	 	5.	Investment. You acknowledge and agree that any investment in any securities of Propex Fabrics Holdings Inc (“Holdings”) by you or any decision by you not to make
any such investment is not a condition to, or in any way related to this Offer or your employment. 

  

 Mr. Edmund A. Stanczak, Jr. 
  
 August 11, 2005 
  

	 	6.	Stock Option Plan. You will be granted 14,000 stock options in the stock option plan of Holdings, upon such terms as are approved by the Board of Directors of Holdings (the
“Holdings Board”) or a duly authorized committee, thereof, subject to the approval of such stock option plan by the Holdings Board and the stockholders of Holdings, provided that you understand and agree that your participation in such
stock option plan is not a condition to your employment and that stock options to be granted, if any, will be determined at the discretion of the Holdings Board. 

  

	 	7.	Bonus Plan. For 2005, you will be eligible for a target bonus payment of 75% of your 2005 bonus-eligible earnings (the “Target Bonus”) if Propex meets its budgeted
EBITDA for 2005 as well as other strategic objectives. Bonus-eligible earnings include your base salary earned in 2005, but exclude other compensation including any applicable relocation reimbursement etc. It is expected that some percentage of the
Target Bonus would be paid if Propex meets a significant percentage (to be determined by the Board of Directors of Propex (the “Propex Board”)) of its 2005 objectives. In the event that Propex exceeds its 2005 objectives, you will be
eligible to receive an additional bonus payment, for 2005, which will be determined at the discretion of the Propex Board. For 2006 and beyond, the Propex Board will determine Target Bonuses, however, such future Target Bonuses for any given year
will not be less than those that would have been paid had the 2005 Bonus Plan been in effect for that year. 

  

	 	8.	Severance Payment. As set forth herein, Propex may terminate your employment at any time with or without Cause as defined in Exhibit A attached hereto. If your employment is
terminated by Propex without Cause or due to your death or total and permanent disability (as such total and permanent disability is reasonably determined by the Propex Board), you will (i) receive (subject to statutory withholdings and deductions)
a severance payment equal to the sum of 175% of one year’s Annual Salary, and (ii) (in the case of termination by Propex without Cause) comply with the provisions of paragraph 9(b)-(d) hereof. If your employment is terminated by Propex with
Cause, by your voluntary resignation or under any other circumstances not addressed in the preceding sentence, you will (i) receive (to the extent not theretofore paid) the portion of your Annual Salary for the portion of the year in which such
termination occurs (subject to statutory withholdings and deductions), (ii) receive no other payment or compensation and (iii) comply with the provisions of paragraph 9(b)-(d) hereof. 

  

	 	9.	Non-Competition Covenant. 

  

	 	(a)	During your employment with Propex, you will not compete with Propex or its affiliates, directly or indirectly, either for yourself or as a member of a partnership or as a
stockholder (except as a stockholder of Holdings or as a stockholder of less than one percent of the issued and outstanding stock of a publicly-held company whose gross assets exceed $100 million), investor, owner, officer, director, trustee or
manager of a company or other entity, or as 

  

 Mr. Edmund A. Stanczak, Jr. 
  
 August 11, 2005 
  
 an employee, agent, associate or consultant of any person, partnership, corporation, or other entity, in any business in competition with that carried on
by Propex or any of its affiliated companies. 
  

	 	(b)	During the Non-Compete Term, as defined in subparagraph 9(c) below, you will not (a) represent, engage in, carry on, or have a financial interest in, directly or indirectly,
individually, as a member of a partnership or limited liability company, equity owner, stockholder (other than as a stockholder of Holdings or as a stockholder of less than one percent (1%) of the issued and outstanding stock of a publicly-held
company whose gross assets exceed $100 million), investor, owner, officer, director, trustee, manager, employee, agent, associate or consultant, in any business which directly competes with any of the services or products produced, sold, conducted,
developed, or in the process of development by Propex and its affiliated companies on the date of termination of your employment within a 300 mile radius of Austell, Georgia, or (b) directly or indirectly, whether as a principal, agent, officer,
director, manager, employee, consultant, independent contractor or otherwise, alone in association with or on behalf of any other person, firm, corporation or other business organization, (1) solicit, sell, call upon, advise do or attempt to do
business with or otherwise contact any customer of Propex, its parent, subsidiaries, or other affiliate companies as of the date of such termination, or (2) (i) hire or attempt to hire any employee of Propex, its parent, subsidiaries, or other
affiliate companies, (ii) assist in such hiring by any other person, (iii) encourage any such employee to terminate his/her employment with Propex, its parent, subsidiaries or other affiliated companies (iv) solicit, encourage or induce any
customer, supplier or other person or entity having a business relationship with Propex, its parent, subsidiaries or other affiliated companies to reduce, limit or terminate its business relationship with Propex, its parent, subsidiaries or other
affiliated companies and/or (v) make any statement (orally or in writing) about Propex, its parent or any of its subsidiary or other affiliated companies or any of their products or services, which statement could reasonably be expected to be
detrimental to Propex, its parent or any of its subsidiaries or other affiliated companies or the marketing or sale of any of their their products or services. 

  

	 	(c)	The “Non-Compete Term” is for one year beginning on the date of termination of your employment; provided, however, the foregoing notwithstanding, the Non-Compete Term may
be extended for an additional year upon written notice by Propex provided to you at least six (6) months prior to the end of the first year of the Non-Compete Term and payment of an additional amount equal to 175% of one year’s Annual Salary
(which additional amount will be payable at the start of the second year of the Non-Compete Term, in the event that the Non-Compete Term is extended by the Company). 

  

	 	(d)	You acknowledge that the limitations set forth herein on your rights to compete with Propex and its affiliated companies are reasonable and necessary for the protection of Propex
and its affiliated companies. In this regard, you hereby specifically agree that the limitations as to period of time and geographic area, 

  

 Mr. Edmund A. Stanczak, Jr. 
  
 August 11, 2005 
  
 as well as all other restrictions on your activities specified herein, are reasonable and necessary for the protection of Propex and its affiliated
companies. You agree that, in the event that the provisions of this Offer should ever be deemed to exceed the scope of business, time or geographic limitations permitted by applicable law, such provisions shall be and are hereby reformed to the
maximum scope of business, time or geographic limitations permitted by applicable law. 
  

	 	10.	“At-Will” employment. Your employment will be “at-will.” This means that you may cease your employment or be terminated from employment at any time,
without notice or requirement of Cause or for any or no reason; provided that you receive the payments described in paragraph 8 above in connection with the termination of your employment as set forth therein, but shall be entitled to the other
payment or compensation. Nothing contained in this Offer will be construed to constitute a continued obligation with respect to your employment, or affect your status, as an employee “at-will”. 

  

	 	11.	Contingencies. Your employment offer is contingent upon the following; (1) the information and qualifications you provided during our selection process, which are subject to
verification; (2) the results of a pre-placement drug and alcohol screening; and (3) establishing employment eligibility under the Immigration Reform and Control Act of 1986. You will complete an Employment Eligibility Form on your first day of
employment, and will need to furnish original documents or certified copies only. 

  

	 	12.	Governing Law. This offer shall be governed by, and construed and enforced in accordance with the laws of the State of Georgia. 

  
 Your starting date is set as August 16, 2005 and is contingent upon your
successful fulfillment of the requirements set forth in paragraph 11 above. To make arrangements for the drug and alcohol screening, please contact Cheryl Perkins in Austell-Human Resources at 770-944-4431. Cheryl can also help you with enrollment
in our various benefit plans. 
  
 Ed, we are very pleased that
you are joining us at Propex Fabrics. Please sign and return a counterpart of this letter indicating your acceptance of employment on the terms, described herein. Please contact me at 336-337-5301 or Ken Dirks, VP-Human Resources at 770-944-4430 if
you have any questions. 
  

	
	Sincerely,
	
	 George W. Henderson III

	 Chairman of the Board

  

 Mr. Edmund A. Stanczak, Jr. 
  
 August 11, 2005 
  
 I have read, understood and agree to be bound by the above and accept employment on the above terms as of August 16, 2005. 
  

			
	 	 	 /s/ Edmund Stanczak, Jr.

	 	 	Edmund Stanczak, Jr.
		
	 	 	Date: August 11, 2005

  
 EXHIBIT A

  
 Definition of “Cause”. When used in connection with the
termination of your employment with Propex, or any of its affiliate companies, “Cause” means: (i) breach of your obligations under this Offer after you have been given notice specifying such breach and a reasonable opportunity to cure such
breach; (ii) failure to adhere to any written policy of Propex and its affiliated companies after you have been given notice specifying the failure and a reasonable opportunity to comply with such a policy or cure your failure to comply; (iii) your
conviction of, indictment for or the entering of a guilty plea or plea of no contest with respect to, a felony, the equivalent thereof, or any other crime with respect to which imprisonment is a possible punishment; (iv) the commission by you of an
act of fraud upon Propex or any of its affiliated companies; (v) the misappropriation (or attempted misappropriation) of any funds or property of Propex or any of its affiliated companies; (vi) failure to perform the duties assigned to you under
this Offer after reasonable notice and opportunity to cure such performance; (vii) your engagement in any direct, material conflict of interest with Propex or any of its affiliated companies without compliance with the conflict of interest policy of
Propex or any of its affiliated companies, if any, then in effect; (viii) your engagement, without the written approval of the Board of Directors of Propex, in any activity which competes with the business of Propex or any of its affiliated
companies or which would result in a material injury to Propex or any of its affiliated companies; (ix) your engagement in any activity which would constitute a material violation of the provisions of the Propex or any of its affiliated companies
insider trading policy or business ethics policy, if any then in effect, or (x) any act or omission that, in the judgment of the Board of Directors of Propex has or could have a material adverse effect on (a) Propex’s properties, operations or
public image, or (b) the health, safety or morale of any of the suppliers, employees or customers of Propex or any of its affiliated companies.Executive Severance Agreement

 EXHIBIT 10.1 
  
 EXECUTIVE SEVERANCE AGREEMENT 
  

AGREEMENT made as of this 10th day of August, 2005 by and between ZOLL Medical Corporation, a Massachusetts corporation with its principal place of business in Chelmsford, Massachusetts (the “Company”), and Alexander Moghadam of Acton, Massachusetts
(the “Executive”). 
  
 1. Purpose. The Company
considers it essential to the best interests of its stockholders to foster the continuous employment of key management personnel. The Board of Directors of the Company (the “Board”) recognizes, however, that, as is the case with many
publicly held corporations, the uncertainty and questions which may arise among management in connection with a Change in Control (as defined in Section 2 hereof) may result in the departure or distraction of management personnel to the detriment of
the Company and its stockholders. Therefore, the Board has determined that appropriate steps should be taken to reinforce and encourage the continued attention and dedication of members of the Company’s management, including the Executive, to
their assigned duties without distraction in the face of potentially disturbing circumstances arising from the possibility of a Change in Control. Nothing in this Agreement shall be construed as creating an express or implied contract of employment
and, except as otherwise agreed in writing between the Executive and the Company, the Executive shall not have any right to be retained in the employ of the Company. 
  
 2. Change in Control. A “Change in Control” shall be deemed to have occurred in any one of the following
events: 
  
 (a) any “person,” as such term is used in
Sections 13(d) and 14(d) of the Securities Exchange Act of 1934 (the “Act”) (other than the Company, any of its subsidiaries, or any trustee, fiduciary or other person or entity holding securities under any employee benefit plan or trust
of the Company or any of its subsidiaries), together with all “affiliates” and “associates” (as such terms are defined in Rule 12b-2 under the Act) of such person, shall become the “beneficial owner” (as such term is
defined in Rule 13d-3 under the Act), directly or indirectly, of securities of the Company representing 25% or more of either (A) the combined voting power of the Company’s then outstanding securities having the right to vote in an election of
the Company’s Board of Directors (“Voting Securities”) or (B) the then outstanding shares of stock of the Company (in either such case other than as a result of an acquisition of securities directly from the Company); or 

 
 (b) persons who, as of the date hereof, constitute the Company’s
Board of Directors (the “Incumbent Directors”) cease for any reason, including, without limitation, as a result of a tender offer, proxy contest, merger or similar transaction, to constitute at least a majority of the Board, provided that
any person becoming a director of the Company subsequent to the date hereof whose election or nomination for election was approved by a vote of at least a majority of the Incumbent Directors shall, for purposes of this Agreement, be considered as
Incumbent Director provided, however, that there shall be excluded for consideration as Incumbent Director 

  

 1 

 
any individual whose initial assumption of office occurred as a result of an actual or threatened election contest with respect to the election or removal of
directors or other actual or threatened solicitation of proxies or consents, by or on behalf of a person other than the Board of Directors; or 
  
 (c) the consummation of a transaction by the Company involving: (A) any consolidation or merger of the Company or any Subsidiary where the stockholders of
the Company, immediately prior to the consolidation or merger, would not, immediately after the consolidation or merger, beneficially own (as such term is defined in Rule 13d-3 under the Act), directly or indirectly, shares representing in the
aggregate more than 50% of the voting shares of the corporation issuing cash or securities in the consolidation or merger (or of its ultimate parent corporation, if any), (B) any sale, lease, exchange or other transfer (in one transaction or a
series of transactions contemplated or arranged by any party as a single plan) of all or substantially all of the assets of the Company or (C) any plan or proposal for the liquidation or dissolution of the Company. 
  
 Notwithstanding the foregoing, a “Change in Control” shall not be
deemed to have occurred for purposes of the foregoing clause (a) solely as the result of an acquisition of securities by the Company which, by reducing the number of shares of stock or other Voting Securities outstanding, increases (x) the
proportionate number of shares of stock beneficially owned by any person to 25% or more of the shares of stock then outstanding or (y) the proportionate voting power represented by the Voting Securities beneficially owned by any person to 25% or
more of the combined voting power of all then outstanding Voting Securities; provided, however, that if any person referred to in clause (x) or (y) of this sentence shall thereafter become the beneficial owner of any additional shares
of stock or other Voting Securities (other than pursuant to a stock split, stock dividend, or similar transaction), then a “Change in Control” shall be deemed to have occurred for purposes of the foregoing clause (a). 
  
 3. Terminating Event. A “Terminating Event” shall mean any
of the events provided in this Section 3 occurring subsequent to a Change in Control as defined in Section 2: 
  
 (a) termination by the Company of the employment of the Executive with the Company for any reason other than (A) a willful act of dishonesty by the
Executive with respect to any material matter involving the Company or any subsidiary or affiliate, or (B) conviction of the Executive of a crime involving moral turpitude, or (C) the gross or willful failure by the Executive to substantially
perform the Executive’s duties with the Company (other than any such failure after Executive gives notice of termination for good reason), which failure is not cured within 30 days after a written demand for substantial performance is received
by the Executive from the Board of Directors of the Company which specifically identifies the manner in which the Board of Directors believes the Executive has not substantially performed the Executive’s duties; or (D) the failure by the
Executive to perform his full-time duties with the Company by reason of his death, disability or retirement; provided, however, that a Terminating Event shall not be deemed to have occurred pursuant to this Section 3(a) solely as a
result of the Executive being an employee of any direct or indirect successor to the business or assets of the Company, rather than continuing as an employee of the Company following a Change in Control. For purposes of clauses (A) and (C) of this
Section 3(a), no act, or failure to act, on the Executive’s 
  

 2 

 part shall be deemed “willful” unless done, or omitted to be done, by the Executive without reasonable belief
that the Executive’s act, or failure to act, was in the best interest of the Company and its subsidiaries and affiliates. For purposes of clause (D) of this Section 3(a), Section 6 and Section 8(b) hereof, “disability” shall mean the
Executive’s incapacity due to physical or mental illness which has caused the Executive to be absent from the full-time performance of his duties with the Company for a period of six (6) consecutive months if the Company shall have given the
Executive a Notice of Termination and, within thirty (30) days after such Notice of Termination is given, the Executive shall not have returned to the full-time performance of his duties. For purposes of clause (D) of this Section 3(a) and Section
6, “retirement” shall mean termination of the Executive’s employment in accordance with the Company’s normal retirement policy, not including early retirement, generally applicable to its salaried employees, as in effect
immediately prior to the Change in Control, or in accordance with any retirement arrangement established with respect to the Executive with the Executive’s express written consent; 
  
 (b) termination by the Executive of the Executive’s employment with the Company for Good Reason. Good Reason shall mean
the occurrence of any of the following events: 
  
 (i) a
substantial adverse change, not consented to by the Executive, in the nature or scope of the Executive’s responsibilities, authorities, powers, functions or duties from the responsibilities, authorities, powers, functions or duties exercised by
the Executive immediately prior to the Change in Control; or 
  
 (ii) a reduction in the Executive’s annual base salary as in effect on the date hereof or as the same may be increased from time to time except for across-the-board salary reductions similarly affecting all or substantially all
management employees; or 
  
 (iii) the relocation of the
Company’s offices at which the Executive is principally employed immediately prior to the date of a Change in Control to a location more than 50 miles from such offices, or the requirement by the Company for the Executive to be based anywhere
other than the Company’s offices at such location, except for required travel on the Company’s business to an extent substantially consistent with the Executive’s business travel obligations immediately prior to the Change in Control;
or 
  
 (iv) the failure by the Company to pay to the Executive any
portion of his compensation or to pay to the Executive any portion of an installment of deferred compensation under any deferred compensation program of the Company within 15 days of the date such compensation is due without prior written consent of
the Executive; or 
  
 (v) the failure by the Company to obtain an
effective agreement from any successor to assume and agree to perform this Agreement, as required by Section 16. 
  
 4. Severance Payment. In the event a Terminating Event occurs within eighteen (18) months after a Change in Control, 
  

 3 

 (a) the Company shall pay to the Executive an amount equal to one and one-half (1.5) times the sum of (i)
the Executive’s base salary immediately prior to the Terminating Event (or immediately prior to the Change in Control, if higher) and (ii) the average of the bonuses paid to the Executive over the three most recent years prior to the Change in
Control, payable in one lump-sum payment on the Date of Termination; 
  
 (b) the Company shall continue to provide health and dental insurance coverage to the Executive, on the same terms and conditions as though the Executive had remained an active employee, for eighteen (18) months after the Terminating Event;
and 
  
 (c) the Company shall pay to the Executive all reasonable
legal and arbitration fees and expenses incurred by the Executive in obtaining or enforcing any right or benefit provided by this Agreement, except in cases involving frivolous or bad faith litigation. 
  
 5. Additional Benefits. 
  
 (a) Anything in this Agreement to the contrary notwithstanding, in the event
it shall be determined that any compensation, payment or distribution by the Company to or for the benefit of the Executive, whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise, (the
“Severance Payments”), would be subject to the excise tax imposed by Section 4999 of the Internal Revenue Code of 1986, as amended (the “Code”), the following provisions shall apply: 
  
 (i) If the Severance Payments, reduced by the sum of (1) the
Excise Tax and (2) the total of the Federal, state, and local income and employment taxes payable by the Executive on the amount of the Severance Payments which are in excess of the Threshold Amount, are greater than or equal to the Threshold
Amount, the Executive shall be entitled to the full benefits payable under this Agreement. 
  
 (ii) If the Threshold Amount is less than (x) the Severance Payments, but greater than (y) the Severance Payments reduced by the sum of
(1) the Excise Tax and (2) the total of the Federal, state, and local income and employment taxes on the amount of the Severance Payments which are in excess of the Threshold Amount, then the benefits payable under this Agreement shall be reduced
(but not below zero) to the extent necessary so that the maximum Severance Payments shall not exceed the Threshold Amount. To the extent that there is more than one method of reducing the payments to bring them within the Threshold Amount, the
Executive shall determine which method shall be followed; provided that if the Executive fails to make such determination within 45 days after the Company has sent the Executive written notice of the need for such reduction, the Company may
determine the amount of such reduction in its sole discretion. 
  
 For the
purposes of this Section 5, “Threshold Amount” shall mean three times the Executive’s “base amount” within the meaning of Section 280G(b)(3) of the Code and the regulations promulgated thereunder less one dollar ($1.00); and
“Excise Tax” shall mean the excise tax imposed by Section 4999 of the Code, or any interest or penalties incurred by the Executive with respect to such excise tax. 
  
  

 4 

 (b) The determination as to which of the alternative provisions of Section 5(a) shall apply to the
Executive shall be made by Ernst & Young LLP or any other nationally recognized accounting firm selected by the Company (the “Accounting Firm”), which shall provide detailed supporting calculations both to the Company and the Executive
within 15 business days of the Date of Termination, if applicable, or at such earlier time as is reasonably requested by the Company or the Executive. For purposes of determining which of the alternative provisions of Section 5(a) shall apply, the
Executive shall be deemed to pay federal income taxes at the highest marginal rate of federal income taxation applicable to individuals for the calendar year in which the determination is to be made, and state and local income taxes at the highest
marginal rates of individual taxation in the state and locality of the Executive’s residence on the Date of Termination, net of the maximum reduction in federal income taxes which could be obtained from deduction of such state and local taxes.
Any determination by the Accounting Firm shall be binding upon the Company and the Executive. 
  
 6. Term. This Agreement shall take effect on the date first set forth above and shall terminate upon the earlier of (a) the termination by the Company of the employment of the Executive because of (A) a willful
act of dishonesty by the Executive with respect to any material matter involving the Company or any subsidiary or affiliate, or (B) conviction of the Executive of a crime involving moral turpitude, or (C) the gross or willful failure by the
Executive to substantially perform the Executive’s duties with the Company, or (D) the failure by the Executive to perform his full-time duties with the Company by reason of his death, disability (as defined in Section 3(a)) or retirement (as
defined in Section 3(a)), (b) the resignation or termination of the Executive for any reason prior to a Change in Control, (c) the resignation of the Executive after a Change in Control for any reason other than the occurrence of any of the events
enumerated in Section 3(b)(i)-(v) of this Agreement, or (d) the date which is eighteen (18) months after a Change in Control if the Executive is still employed by the Company. 
  
 7. Withholding. All payments made by the Company under this Agreement shall be net of any tax or other amounts
required to be withheld by the Company under applicable law. 
  
 8. Notice and Date of Termination; Disputes; Etc. 
  
 (a) Notice of Termination. After a Change in Control and during the term of this Agreement, any purported termination of the Executive’s employment (other than by reason of death) shall be communicated by written Notice of
Termination from one party hereto to the other party hereto in accordance with this Section 8. For purposes of this Agreement, a “Notice of Termination” shall mean a notice which shall indicate the specific termination provision in this
Agreement relied upon and the Date of Termination. Further, a Notice of Termination pursuant to one or more of clauses (A) through (C) of Section 3(a) hereof is required to include a copy of a resolution duly adopted by the affirmative vote of not
less than two-thirds (2/3) of the entire membership of the Board at a meeting of the Board (after reasonable notice to the Executive and an opportunity for the Executive, accompanied by the Executive’s counsel, to be heard before the Board)
finding that, in the good faith opinion of the Board, the termination met the criteria set forth in one or more of clauses (A) through (C) of Section 3(a) hereof. 
  
  

 5 

 (b) Date of Termination. “Date of Termination”, with respect to any purported
termination of the Executive’s employment after a Change in Control and during the term of this Agreement, shall mean (i) if the Executive’s employment is terminated for disability, 30 days after the Notice of Termination is given
(provided that the Executive shall not have returned to the full-time performance of the Executive’s duties during such 30-day period) and (ii) if the Executive’s employment is terminated for any other reason, the date specified in the
Notice of Termination. In the case of a termination by the Company other than a termination pursuant to one or more of clauses (A) through (C) of Section 3(a) (which may be effective immediately), the Date of Termination shall be 30 days after the
Notice of Termination is given. In the case of a termination by the Executive, the Date of Termination shall not be less than 15 days from the date such Notice of Termination is given. Notwithstanding Section 3(a) of this Agreement, in the event
that the Executive gives a Notice of Termination to the Company, the Company may unilaterally accelerate the Date of Termination and such acceleration shall not result in a Terminating Event for purposes of Section 3(a) of this Agreement.

  
 (c) No Mitigation. The Company agrees that, if the
Executive’s employment by the Company is terminated during the term of this Agreement, the Executive is not required to seek other employment or to attempt in any way to reduce any amounts payable to the Executive by the Company pursuant to
Sections 4(a), (b) and (c) hereof. Further, the amount of any payment provided for in this Agreement shall not be reduced by any compensation earned by the Executive as the result of employment by another employer, by retirement benefits, by offset
against any amount claimed to be owed by the Executive to the Company or otherwise. 
  
 (d) Settlement and Arbitration of Disputes. Any controversy or claim arising out of or relating to this Agreement or the breach thereof shall be settled exclusively by arbitration in accordance with the laws of
the Commonwealth of Massachusetts by three arbitrators, one of whom shall be appointed by the Company, one by the Executive and the third by the first two arbitrators. If the first two arbitrators cannot agree on the appointment of a third
arbitrator, then the third arbitrator shall be appointed by the American Arbitration Association in the City of Boston. Such arbitration shall be conducted in the City of Boston in accordance with the rules of the American Arbitration Association
for commercial arbitrations, except with respect to the selection of arbitrators which shall be as provided in this Section 8(d). Judgment upon the award rendered by the arbitrators may be entered in any court having jurisdiction thereof.

  
 9. Successor to Executive. This Agreement shall inure
to the benefit of and be enforceable by the Executive’s personal representatives, executors, administrators, heirs, distributees, devisees and legatees. In the event of the Executive’s death after a Terminating Event but prior to the
completion by the Company of all payments due him under Section 4(a), (b) and (c) of this Agreement, the Company shall continue such payments to the Executive’s beneficiary designated in writing to the Company prior to his death (or to his
estate, if the Executive fails to make such designation). 
  

 6 

 10. Enforceability. If any portion or provision of this Agreement shall to any extent be declared
illegal or unenforceable by a court of competent jurisdiction, then the remainder of this Agreement, or the application of such portion or provision in circumstances other than those as to which it is so declared illegal or unenforceable, shall not
be affected thereby, and each portion and provision of this Agreement shall be valid and enforceable to the fullest extent permitted by law. 
  
 11. Waiver. No waiver of any provision hereof shall be effective unless made in writing and signed by the waiving party. The failure of any party
to require the performance of any term or obligation of this Agreement, or the waiver by any party of any breach of this Agreement, shall not prevent any subsequent enforcement of such term or obligation or be deemed a waiver of any subsequent
breach. 
  
 12. Notices. Any notices, requests, demands and
other communications provided for by this Agreement shall be sufficient if in writing and delivered in person or sent by registered or certified mail, postage prepaid, to the Executive at the last address the Executive has filed in writing with the
Company, or to the Company at its main office, attention of the Board of Directors. 
  
 13. Effect on Other Plans. An election by the Executive to resign after a Change in Control under the provisions of this Agreement shall not be deemed a voluntary termination of employment by the Executive for
the purpose of interpreting the provisions of any of the Company’s benefit plans, programs or policies. Nothing in this Agreement shall be construed to limit the rights of the Executive under the Company’s benefit plans, programs or
policies except as otherwise provided in Section 5 hereof, and except that the Executive shall have no rights to any severance benefits under any severance pay plan. 
  
 14. Amendment. This Agreement may be amended or modified only by a written instrument signed by the Executive and by
a duly authorized representative of the Company. 
  
 15.
Governing Law. This is a Massachusetts contract and shall be construed under and be governed in all respects by the laws of the Commonwealth of Massachusetts. 
  
 16. Obligations of Successors. The Company shall require any successor (whether direct or indirect, by purchase,
merger, consolidation or otherwise) to all or substantially all of the business or assets of the Company to expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform
if no such succession had taken place. 
  
 17. Confidential
Information. The Executive shall never use, publish or disclose in a manner adverse to the Company’s interests, any proprietary or confidential information relating to (a) the business, operations or properties of the Company or any
subsidiary or other affiliate of the Company, or (b) any materials, processes, business practices, technology, know-how, research, programs, customer lists, customer requirements or other information used in the manufacture, sale or marketing of any
of the respective products or services of the Company or any subsidiary or other affiliate of the Company; provided, however, that no breach or alleged 
  

 7 

 breach of this Section 17 shall entitle the Company to fail to comply fully and in a timely manner with any other
provision hereof. Nothing in this Agreement shall preclude the Company from seeking money damages, or equitable relief by injunction or otherwise without the necessity of proving actual damage to the Company, for any breach by the Executive
hereunder. 
  
 IN WITNESS WHEREOF, this Agreement has been
executed as a sealed instrument by the Company by its duly authorized officer, and by the Executive, as of the date first above written. 
  

			
	ZOLL MEDICAL CORPORATION
		
	By:	 	 /s/ Richard A. Packer

	Name:	 	Richard A. Packer
	Title:	 	Chief Executive Officer
		
	 	 	 /s/ Alexander Moghadam

	 	 	Alexander Moghadam

  

 8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00089-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00089-of-00352.parquet"}]]